This message was sent to ##Email##
|Announcing the 2nd Annual George L. Blackburn Award for Excellence!
The Obesity Society (TOS) is proud and honored to announce that Donna H. Ryan, MD, FTOS, is the 2019 recipient of the 2nd Annual George L. Blackburn Award for Excellence. Given by The Obesity Society this important award recognizes a member who best exemplifies Dr. Blackburn's success in combining translational research with evidence-based practice in Obesity Medicine. The awardee is a clinician who has successfully translated the science of nutrition, metabolism and obesity into effective clinical practice and has been a leader in guiding other practitioners to do the same.
Dr. Ryan, a member of the faculty at the Pennington Biomedical Center since 1988, is a Past President of TOS, and currently serves as the Associate Editor-in-Chief of Obesity as well as being the current President of the World Obesity Federation. Dr. Ryan's contributions to, and influence on, the field of Obesity Medicine clearly exemplifies the accomplishments for which the George Blackburn Award for Excellence was established to recognize.
This prestigious award is funded by the Center for Nutritional Research Charitable Trust (CNRCT) in honor of George L. Blackburn, MD, PhD, also a TOS Past President, whose long and distinguished career spanned nutrition, and metabolism and obesity, and whose clinical teaching focused on the important role of nutrition in maintaining health and preventing disease, and had a major impact across multiple disciplines including bariatric surgery, nutritional and metabolic research, and clinical practice. In addition, he is a dedicated teacher and mentor. Thanks to the generosity of CNRCT, the recipient receives both a plaque honoring her contributions to the field of obesity, and a $5,000 award.
Please join us for the award presentation ceremony taking place during the GEORGE L. BLACKBURN SYMPOSIUM on Wednesday, Nov. 6, from 10:30 a.m. – 12:00 p.m. at the Mandalay Bay South Convention Center.
Susan G. Komen® / TOS
|Closing Oct. 4 — Susan G. Komen® Breast Cancer Challenge
Susan G. Komen® Breast Cancer Challenge presented by The Obesity Society: Obesity and Cancer Section
Junior investigators are invited to submit a one-page letter of intent (LOI) in response to the Susan G. Komen® Breast Cancer Challenge. Komen has set a Bold Goal to reduce the current number of breast cancer deaths by 50 percent in the U.S. by 2026. Find more about Komen's Bold Goal.
Specifically, the research described in the LOI should focus on answering one of the following questions relevant to Komen's Bold Goal:
Applications from across the translational continuum are invited, from genes to geography.
- Is the development of specific subtypes of breast cancer associated with obesity? What factors contribute to patients with obesity having an elevated risk of recurrence or developing metastatic breast cancer?
- How does obesity influence the efficacy of breast cancer treatments?
- Does obesity contribute to breast cancer disparities? Are patients with obesity of a specific race or ethnicity at a higher risk of having poor clinical outcomes?
- Do diet and/or exercise interventions reduce the risk of recurrence alone or is it the associated weight loss that reduces the risk of having a recurrence or developing metastatic breast cancer? What are the mechanisms associated with weight, diet, and/or exercise that influence the onset of breast cancer recurrence?
Junior investigators are defined broadly as:
Submission and Selection
- Completed doctoral level training less than 8 years ago.
- Holds a position of post-doc, fellow, or assistant professor at an academic institution.
- No citizenship requirement (international applicants welcome).
The LOI is due Oct. 4, 2019, by 12 noon (EST), and can be submitted to Shameeka Green at email@example.com.
A panel of experts from basic, clinical, and population sciences, along with a breast cancer research advocates, will review the LOIs and choose 5 semi-finalists. All semi-finalists must attend The Obesity Society's (TOS) Obesity and Cancer Section meeting at the 2019 ObesityWeek® conference to be eligible as a finalist. The 5 semi-finalists will have 10 minutes to present their proposal with 3 finalists chosen based on the presentations.
Based on the review of the submitted LOIs, five individuals will be invited to present their proposals at the Obesity and Cancer Section meeting at the 2019 ObesityWeek® conference. Based on these presentations, three individuals will be selected as grant recipients. Each grantee will receive a $5,000 award to be used to conduct the research proposed in their LOI/presentation. The period of funding for the pilot program will be for one year. All three winners will be asked to provide a final written report. The grantee will also have to present the results of their pilot studies at the 2020 ObesityWeek® conference in Atlanta, GA, during a session devoted to results from Susan G. Komen® Breast Cancer Challenge.
TOS's Obesity and Cancer Section meeting will be held on Tuesday, Nov. 5, 2019, 10:15 a.m.-11:45 a.m. in the Mandalay Bay South Convention Center, Mandalay Bay C, Las Vegas, NV.
|Closing Oct. 6 — The 2019 Voting for TOS Vice President, Council and Nominating Committee Members
Members of The Obesity Society (TOS) are casting ballots for Vice President, as well as Council and Nominating Committee positions. Eligible members and Fellows can vote on our election website, Simply Voting.
Active members should have received an email from Simply Voting with their unique ID number and password. Ballots can be cast directly through a link in the email, or by visiting the TOS website and following the path through the provided link.
Did you know over 400 ballots have already been cast and 13 percent of those were international members. Voting closes Sunday — cast your vote now!
|TOS Members Author Review in JAMA
Three members of The Obesity Society have authored a review in the Journal of the American Medical Association (JAMA). On Sept. 30, 2019, Michelle Cardel, PhD, MS, RD, FTOS, of the University of Florida College of Medicine in Gainesville, Ania Jastreboff, MD, PhD, of Yale University School of Medicine in New Haven, Conn., and Aaron Kelly, PhD, University of Minnesota Center for Pediatric Obesity Medicine in Minneapolis discussed "Treating of Adolescent Obesity in 2020."
In the paper, Cardel and colleagues address the evidence behind behavioral intervention, pharmacological and weight loss options. The authors argue choice of treatment needs to be guided by the severity of obesity, psychosocial factors, comorbidities, and patient's age and pubertal status.
|| PRODUCT SHOWCASE||Advertisement
The M-Close Kit is a multifunction device specifically designed for patients with obesity. The mechanically-controlled integrated dual needles deliver bilateral targeted abdominal wall anesthesia, AND it’s the most advanced port closure device, capturing consistent tissue bites regardless of the patients abdominal wall thickness. www.NewWaveEndo.com
|In Memoriam: Theodore Van Itallie, MD
Theodore Van Itallie, obesity expert and leading researcher in metabolic diseases, died Sept. 14, 2019, in Old Lyme, CT. He was 99. The author of more than 200 publications, Van Itallie was the first to demonstrate that weight loss was a function of calorie reduction, not changes in the protein or other composition of the diet. He publicly refuted the "calories don't count" school of weight loss and often provided the popular press with responsible medicine's commentary on the latest fad diet.
He did ground-breaking work on numerous metabolic diseases before focusing on obesity in 1975 as the founder of the Obesity Research Center at St. Luke's Hospital in New York, the first such center supported by the National Institutes of Health. There, Van Itallie pioneered work on the regulation of food intake, the mechanism of satiety signals, the physiologic changes in fat cells associated with obesity, and the risks of rapid weight loss. He developed new models for assessment of nutritional status and did early work on the epidemiology of obesity in the United States.
Van Itallie was born in Hackensack, NJ, in 1919. He graduated from Harvard College and Columbia University’s College of Physicians and Surgeons. He was a lieutenant (j.g.) in the Navy Medical Corps. and saw active duty in the Pacific theatre.
Returning from Japan in 1948, Van Itallie completed his residency training at St. Luke's Hospital in New York and accepted a research and teaching position at Harvard Medical School. He returned to St. Luke’s as Director of Medicine in 1957. St. Luke’s became a Columbia University teaching hospital under his leadership.
In 1975, Van Itallie stepped down as Director of Medicine to run the first NIH-funded center for obesity research. He advised numerous government officials and agencies on human nutrition, recommended dietary allowances, dietary fat, advanced teaching of nutrition and surgical treatment of obesity, including the NIH, the White House, the U.S. Surgeon General, the Food and Drug Administration, and the Department of Agriculture.
Retiring from the Obesity Research Center in 1988, Van Itallie continued his devotion to medical research, publishing more than 48 journal articles, consulting on clinical research, and devoting special attention to ketone esters as a therapeutic agent for Parkinson's and Alzheimer's disease.
Van Itallie's first marriage to Barbara Cox ended in divorce. His second wife, Sallie Newton Calhoun, died in 2012. Van Itallie's five children survive him: Lucy Borge of Quogue, NY, Theodore Jr. of Princeton, NJ, Christina Van Itallie of Bethesda, MD, Elizabeth Van Itallie and Katharine Van Itallie of New York City, six grandchildren, and four great-grandchildren.
TOS sends its deepest sympathy to the Van Itallie family.
|Winners of the 7th Annual Obesity Journal Symposium
The editors of Obesity are pleased to announce the five winning papers that will be featured at the 7th annual Obesity Journal Symposium at The 37th Annual Meeting of The Obesity Society (TOS) at ObesityWeek®.
Innovative research designs providing the latest insights into preventing and treating obesity will be presented during the symposium hosted by the editorial team of Obesity, the flagship scientific journal of TOS. Editors-in-Chief Eric Ravussin, PhD, and Donna H. Ryan, MD, will begin the session with a presentation on the state of the journal. The Obesity Journal Symposium will be held Tuesday, Nov. 5, 2019, 3:30-5:00 p.m. in Mandalay Bay C at the Mandalay Bay South Convention Center in Las Vegas, NV.
This year's presentations and winners are:
Children and Adolescents' Anthropometrics Body Composition From 3D Optical Surface Scans, Michael C. Wong
The Pattern of Biliary Disease Following Laparoscopic Sleeve Gastrectomy in Adolescents, Evan P. Nadler, MD
Early Non-Food Parent-Infant Interactions and the Development of Obesity in a High-Risk, Diverse Sample, Kai Ling K. Kong, PhD
Plasma High-Resolution Metabolomics Differentiates Adults with Normal Weight Obesity From Lean Individuals, Moriah P. Bellissimo, MS, RD
Hyper-Palatable Foods: Development of a Quantitative Definition and Application to the United States Food System Database, Tera Fazzino, PhD
Congratulations to these TOS members for their groundbreaking work! Don't forget to add this session to your itinerary as you plan your ObesityWeek® schedule.
|Advance Registration is Extended Until Oct. 7, 2019!
This is your last chance to avoid long lines at registration! Register by Oct. 7, 2019, for advance registration rates to the 37th Annual Meeting of The Obesity Society at ObesityWeek® 2019 — the largest obesity science conference in the world. The conference features cutting-edge research, diverse programming, joint symposia with leaders in the field, and state-of-the-art clinical practice.
Save $20 off registration by using coupon code TOSMEM.
|Pediatric Obesity Section Business Meeting
Take a break from a busy meeting schedule and meet up with your friendly peers from the Pediatric Obesity Section (POS) over a relaxing lunch break. The POS Section meeting will be held from 12 noon to 1:30 p.m., Thursday, Nov. 7, 2019, in Mandalay Bay A, at the Mandalay Bay South Convention Center in Las Vegas.
We will provide you with exciting updates, celebrate and hear from this year's recipient of the Bar-Or Award for Excellence in Pediatric Obesity Research among other topics.
That day, you may also attend an exciting ASMBS/TOS joint session entitled "Pediatric Obesity Treatment — A Global Perspective" with topics spanning the pediatric obesity intervention continuum with an international flare!
|Joint Symposia at ObesityWeek® 2019
As part of the numerous opportunities at ObesityWeek®, The Obesity Society (TOS) will partner with several peer organizations and government agencies to offer joint symposia. Members are encouraged to mark their calendars to attend these sessions scheduled for Nov. 3–7, 2019, at Mandalay Bay in Las Vegas, NV.
Check out a few of the joint symposia to be held on at ObesityWeek® 2019!
Nov. 6, 2019: TOS/Academy Joint Symposia: Partnering for Obesity Treatment in Primary Care and Following Bariatric Surgery—Evidence-based Dietary and Lifestyle Practices for Health Care Providers
Nov. 7, 2019: TOS/OMA Joint Symposium: Nutritional Intervention in the Clinical Management of Diabetes
Nov. 7, 2019: TOS/ACSM Joint Symposium: Is "Sit Less" Sufficient for Obesity Prevention and Treatment? Contemporary Perspectives
Nov. 7, 2019: TOS/SBM Joint Symposium: Understanding Environmental Influences to Tailor Obesity Prevention and Treatment Efforts
Nov. 7, 2019: TOS/WOF Joint Symposium: Sugar — Natural and Pure or is Deadly?
View the conference schedule on the ObesityWeek® website to learn more about joint symposia at ObesityWeek® 2019.
|Beware of Fake Websites for ObesityWeek® 2019
REAL OBESITYWEEK WEBSITE: OBESITYWEEK.COM
The Obesity Society (TOS) wants to alert perspective attendees that fake websites can be found online advertising ObesityWeek® 2019. Individuals are advised to be aware and avoid these websites. These pirate sites are not affiliated in any way with TOS or ObesityWeek®.
The official website for The 37th Annual Meeting of The Obesity Society at ObesityWeek® 2019 can be found here. In searching for information online about ObesityWeek®, look for the TOS logo to ensure you are using the correct website.
If you have any questions or concerns, please send an email to firstname.lastname@example.org.
National Institutes of Health
|High-Risk, High-Reward Research Program Award Winners Announced
The National Institutes of Health (NIH) awarded 93 grants through its High-Risk, High-Reward Research Program that will fund highly innovative biomedical or behavioral research proposed by extraordinarily creative scientists. Examples of supported research include exploring how the brain maximizes storage capacity, developing a new approach to treating bacterial infections without the use of antibiotics, understanding the genetic rules that allow one cell type to convert to another, and uncovering a novel potent method for treating adolescent depression. The 93 awards total approximately $267 million over five years, pending available funds.
The High-Risk, High-Reward Research program catalyzes scientific discovery by supporting highly innovative research proposals that, due to their inherent risk, may struggle in the traditional peer review process despite their transformative potential. Program applicants are encouraged to think outside-the-box and to pursue trailblazing ideas in any area of research relevant to the NIH mission.
| || |
The Obesity Society eNews
Connect with TOS
Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version
Robyn Gordon, News Editor, The Obesity Society | Contribute News
Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit
The Obesity Society
1110 Bonifant Street, Suite 500 | Silver Spring, MD 20910 | 301-563-6526 | Contact Us
Disclaimer: eNews is a digest of the most important news selected for The Obesity Society from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Obesity Society does not endorse any of the advertised products and services. Opinions expressed in the articles are those of the author and not of The Obesity Society.
Learn how to add us to your safe sender list so our emails get to your inbox.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063